A worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 60 independent distributors into over 100 countries.
Type
Public
HQ
Mountain View, US
Founded
1989
Size (employees)
121 (est)+13%
Website
iridex.com
IRIDEX was founded in 1989 and is headquartered in Mountain View, US
Report incorrect company information

IRIDEX Office Locations

IRIDEX has an office in Mountain View
Mountain View, US (HQ)
1212 Terra Bella Ave
Show all (1)
Report incorrect company information

IRIDEX Financials and Metrics

IRIDEX Financials

IRIDEX's revenue was reported to be $41.59 m in FY, 2017
USD

Revenue (FY, 2017)

41.6 m

Gross profit (FY, 2017)

15.5 m

Gross profit margin (FY, 2017), %

37.3%

Net income (FY, 2017)

(12.9 m)

EBIT (FY, 2017)

(12.9 m)

Market capitalization (23-Apr-2018)

67.6 m

Cash (30-Dec-2017)

21.7 m
IRIDEX's current market capitalization is $67.6 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

38.3 m42.8 m41.8 m46.2 m41.6 m

Revenue growth, %

12%(2%)11%

Cost of goods sold

19.7 m21.4 m21.8 m25.3 m26.1 m

Gross profit

18.6 m21.4 m20 m20.8 m15.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017

Revenue

9.5 m10.3 m10.6 m10.1 m9.8 m10.8 m9 m9.8 m11.9 m11.9 m10.5 m10 m

Cost of goods sold

4.8 m5.3 m5.3 m5 m5 m5.4 m4.8 m5.5 m6.6 m6.2 m6 m5.5 m

Gross profit

4.7 m5.1 m5.3 m5.1 m4.8 m5.4 m4.2 m4.2 m5.3 m5.7 m4.5 m4.5 m

Gross profit Margin, %

50%49%50%51%49%50%47%43%44%48%43%45%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

13.4 m13.3 m10 m23.7 m21.7 m

Inventories

10.6 m9.1 m11.1 m11.6 m9.4 m

Current Assets

32 m32.9 m30.8 m45.9 m39.5 m

PP&E

543 k735 k1.1 m1.5 m1.4 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017

Cash

14.1 m14 m12.9 m13 m10.2 m13.1 m12.2 m9.6 m10.5 m11.5 m23.9 m24.6 m

Inventories

10 m9.9 m9.8 m9.6 m11.2 m9.9 m10.2 m12.7 m11.1 m12.1 m11.7 m11.4 m

Current Assets

30.4 m31.3 m30.5 m30.8 m31.4 m33.2 m31.9 m31.4 m31.4 m32.7 m45 m43.5 m

PP&E

526 k575 k720 k748 k1.1 m1 m1.1 m1.4 m1.1 m1.2 m1.7 m1.6 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

2.2 m10 m474 k(11.7 m)(12.9 m)

Depreciation and Amortization

490 k420 k522 k648 k858 k

Inventories

(2.5 m)1.5 m(2 m)(537 k)2.1 m

Accounts Payable

173 k(520 k)465 k(229 k)(270 k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017

Net Income

530 k487 k297 k490 k442 k246 k(652 k)(671 k)101 k(328 k)(1.9 m)

Inventories

9.8 m9.6 m11.2 m9.9 m10.2 m12.7 m11.1 m12.1 m11.7 m

Accounts Payable

2 m1.8 m2.6 m2.5 m2.1 m2.5 m2.7 m3.2 m1.9 m
USDY, 2017

Revenue/Employee

363.3 k

Financial Leverage

1.4 x
Show all financial metrics
Report incorrect company information

IRIDEX News and Updates

International Laser Therapy Market 2018 | Financial Business Overview | Industry Growth Rate and Forecasts by 2023

The Global Laser Therapy Market is expected to grow at a CAGR of 9.2% during the forecast period. Laser Therapy industry is segmented into dermatology and aesthetics, surgery, dental, and others. The surgery segment is further segmented into urology, ophthalmology and others. Posted via Industry Tod…
Report incorrect company information